vimarsana.com
Home
Live Updates
No Difference in Psoriasis Immune Response Despite Switch Be
No Difference in Psoriasis Immune Response Despite Switch Be
No Difference in Psoriasis Immune Response Despite Switch Between AVT02, Adalimumab
These data were found to be consistent with the findings in the main study, the contents of which suggested the treatments’ interchangeability.
Related Keywords
Germany ,
Jana Schockaert ,
Nataliya Reznichenko ,
Kathleen Richter ,
Eric Guenzi ,
Fausto Berti ,
Halimun Haliduola ,
,
Alvotech Germany Gmbh ,
Miscellaneous Rheumatic ,
Inflammatory Diseases Poster ,
Psoriasis ,
Adalimumab ,
Humera ,
Interchangeability ,
Avt02 ,
Chronic ,